Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.6700
-0.0001 (-0.01%)
At close: Jan 16, 2026, 4:00 PM EST
0.6809
+0.0109 (1.63%)
After-hours: Jan 16, 2026, 7:49 PM EST

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22
431597327
Market Cap Growth
-54.18%-82.21%-84.31%-70.25%-
Enterprise Value
-3215--
Last Close Price
0.674.78681.446338.685983.49
PE Ratio
-2.69---
PB Ratio
0.110.40-1.39-485.51192.37
P/TBV Ratio
0.360.40--192.37
Debt / Equity Ratio
---0.95--
Quick Ratio
7.7710.550.060.8313.62
Current Ratio
8.0911.040.090.8913.90
Return on Equity (ROE)
-74.29%---468.63%-
Return on Assets (ROA)
-34.44%-54.20%-126.35%-123.25%-
Return on Invested Capital (ROIC)
-43.55%-73.88%--295.49%-
Return on Capital Employed (ROCE)
-35.00%-54.50%25.10%1613.80%-109.20%
Earnings Yield
-92.09%37.25%-335.14%-3.29%-0.57%
FCF Yield
-99.32%-137.84%-19.33%-1.64%-0.43%
Buyback Yield / Dilution
-831.83%-1670.55%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q